TCT 2009 schedule: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 26: | Line 26: | ||
== Monday September 21, 2009== | == Monday September 21, 2009== | ||
===1: | ===1:05 PM=== | ||
''1:05 PM - 1:15 PM'' | ''1:05 PM - 1:15 PM'' | ||
*'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations | *'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations | ||
| Line 67: | Line 67: | ||
== Thursday September 24, 2009== | == Thursday September 24, 2009== | ||
===8: | ===8:46 AM=== | ||
''8:46 AM - 11:11 AM'' | ''8:46 AM - 11:11 AM'' | ||
*'''Event:''' Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 2: Current Choices in Antithrombin Therapy for ACS and PCI | *'''Event:''' Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 2: Current Choices in Antithrombin Therapy for ACS and PCI | ||
Revision as of 13:49, 7 August 2009
Here is the page we will use to coordinate the TV events at TCT 2009.
Click on Date for Detailed Schedule
Sunday September 20, 2009
Monday September 21, 2009
1:05 PM
1:05 PM - 1:15 PM
- Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
- Room: 104
1:51 PM - 2:03 PM
- Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
- Room: 104
Tuesday September 22, 2009
10:00 AM
10:00 AM - 12:00 PM
- Event: Oral Abstracts- AMI
- Room: 125
Wednesday September 23, 2009
12:45 PM
12:45 PM - 12:50 PM
- Event: Open Issues I: Adjunct Pharmacology. Schedule
- Room: 130
1:35 PM
1:35 PM - 1:45 PM
- Event: Open Issues I: Adjunct Pharmacology. Schedule
- Room: 130
4:00 PM
4:00 PM - 4:45 PM
- Event: Main Arena I. Plenary Session #7 Personalized Clinical Decision-Making Case Study: The Ischemia vs. Bleeding Controversy
- Room: Esplanade Ballroom
Thursday September 24, 2009
8:46 AM
8:46 AM - 11:11 AM
- Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 2: Current Choices in Antithrombin Therapy for ACS and PCI
- Room: 135
11:45 PM
11:45 AM - 11:57 AM
- Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
- Room: 135
12:09 PM
12:09 PM - 12:24 PM
- Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
- Room: 135
5:02 PM
5:02 PM - 5:14 PM
- Event: Balancing Safety and Efficacy of Antithrombotic Therapies for PCI and ACS. Antiplatelet Agents, Bleeding, and Ischemia
- Room: 135
Friday September 25, 2009
2:24 PM
2:24 PM - 2:36 PM
- Event: Top Interventional Trials of the Last Year: Perspectives from the Experts
GPIIb/IIIa Inhibitors in ACS: EARLY ACS
- Room: EBM and Guidelines Theater, Hall D
2:36 PM
2:36 PM - 3:12 PM
- Event: Top Interventional Trials of the Last Year: Perspectives from the Experts
Aspirin and Clopiodgrel in ACS: CURRENT-OASIS 7
- Room: EBM and Guidelines Theater, Hall D
3:00 PM
3:00 PM - 3:12 PM
- Event: Top Interventional Trials of the Last Year: Perspectives from the Experts
Aspirin and Clopiodgrel in ACS: CURRENT-OASIS 7
- Room: EBM and Guidelines Theater, Hall D
3:24 PM
3:24 PM - 3:36 PM
- Event: Top Interventional Trials of the Last Year: Perspectives from the Experts
Ticagrelor in ACS: PLATO
- Room: EBM and Guidelines Theater, Hall D
3:36 PM
3:36 PM - 3:48 PM
- Event: Top Interventional Trials of the Last Year: Perspectives from the Experts
Ticagrelor in ACS: PLATO
- Room: EBM and Guidelines Theater, Hall D